Researchers conducted an open-label observational study to assess the safety and efficacy of dextromethorphan/quinidine as migraine prophylaxis for individuals with pseudobulbar affect.
Investigators sought to evaluate the efficacy and tolerability of sTMS for migraine prevention.
The monoclonal antibody erenumab has shown favorable results regarding efficacy and safety for the prevention of migraine.
Eptinezumab, an investigational treatment for migraine prevention, has met its pivotal Phase 3 trial primary endpoint of significant reduction in monthly migraine days vs placebo.
The Food and Drug Administration has accepted a Biologics License Application for the investigational migraine prevention treatment, galcanezumab.
Some patients with migraines prefer nonpharmacological approaches to treatment and for these patients, evidence-based behavioral treatments may be at least as effective for migraine prophylaxis as medication.
Migraine medication prescription patterns and quality of prescribed medications for migraine headache are similar between minorities and other racial groups.
The FDA has accepted for review the Biologics License Application for Aimovig for migraine prophylaxis in patients experiencing more than 4 migraine days per month.
Clinical Pain Advisor Articles
- Opioid Use in Chronic Low Back Pain: A Population Study
- Risks Associated With Co-Administration of Aspirin and Other NSAIDs
- FDA Approves Aimovig for Migraine Prevention
- Stages of Low Back Pain Have Specific Sets of Clinical Indicators
- First Non-Opioid Drug Approved for Managing Opioid Withdrawal Symptoms
- Effect of Prescription Drug Monitoring Programs on Fatal, Nonfatal Drug Overdoses
- Standardized SCS Workflow May Effectively Alleviate Failed Back Surgery Syndrome-Related Pain
- Marijuana Legalization and Opioid Prescribing Rates
- Medical Marijuana Users More Likely to Use Prescription Drugs for Medical, Nonmedical Purposes
- Interbrain Coupling During Handholding Associated With Analgesia, Empathy
- IV Tramadol Significantly Reduces Post-Op Pain in Phase 3 Study
- Telehealth-Delivered Behavioral Therapy, Supportive Care Beneficial for Low Back Pain
- Patient-Controlled Analgesia Pumps Have Low Device-Related Error Rates
- Adding Chiropractic to Usual Care Beneficial for Low Back Pain
- Illness Perceptions Mediate Back Pain, Quality of Life in Early Axial Spondyloarthritis